Report Detail

Request for Sample of this report

Pharma & Healthcare Global Daratumumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3574666
    • |
  • 04 July, 2019
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Daratumumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Daratumumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Johnson＆Johnson

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
100mg Injection
400mg Injection

Market Segment by Applications, can be divided into
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Daratumumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Daratumumab, with price, sales, revenue and global market share of Daratumumab in 2017 and 2018.
Chapter 3, the Daratumumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Daratumumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Daratumumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Daratumumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Daratumumab Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 100mg Injection
      • 1.2.2 400mg Injection
    • 1.3 Market Analysis by Applications
      • 1.3.1 Multiple Myeloma
      • 1.3.2 Diffuse Large B Cell Lymphoma
      • 1.3.3 Follicular Lymphoma
      • 1.3.4 Mantle Cell Lymphoma
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Johnson＆Johnson
      • 2.1.1 Business Overview
      • 2.1.2 Daratumumab Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Johnson＆Johnson Daratumumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Daratumumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Daratumumab Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Daratumumab Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Daratumumab Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Daratumumab Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Daratumumab Market Analysis by Regions

    • 4.1 Global Daratumumab Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Daratumumab Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Daratumumab Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Daratumumab Sales and Growth Rate (2014-2019)
    • 4.3 Europe Daratumumab Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Daratumumab Sales and Growth Rate (2014-2019)
    • 4.5 South America Daratumumab Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Daratumumab Sales and Growth Rate (2014-2019)

    5 North America Daratumumab by Country

    • 5.1 North America Daratumumab Sales, Revenue and Market Share by Country
      • 5.1.1 North America Daratumumab Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Daratumumab Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Daratumumab Sales and Growth Rate (2014-2019)
    • 5.3 Canada Daratumumab Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Daratumumab Sales and Growth Rate (2014-2019)

    6 Europe Daratumumab by Country

    • 6.1 Europe Daratumumab Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Daratumumab Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Daratumumab Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Daratumumab Sales and Growth Rate (2014-2019)
    • 6.3 UK Daratumumab Sales and Growth Rate (2014-2019)
    • 6.4 France Daratumumab Sales and Growth Rate (2014-2019)
    • 6.5 Russia Daratumumab Sales and Growth Rate (2014-2019)
    • 6.6 Italy Daratumumab Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Daratumumab by Country

    • 7.1 Asia-Pacific Daratumumab Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Daratumumab Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Daratumumab Revenue and Market Share by Country (2014-2019)
    • 7.2 China Daratumumab Sales and Growth Rate (2014-2019)
    • 7.3 Japan Daratumumab Sales and Growth Rate (2014-2019)
    • 7.4 Korea Daratumumab Sales and Growth Rate (2014-2019)
    • 7.5 India Daratumumab Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Daratumumab Sales and Growth Rate (2014-2019)

    8 South America Daratumumab by Country

    • 8.1 South America Daratumumab Sales, Revenue and Market Share by Country
      • 8.1.1 South America Daratumumab Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Daratumumab Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Daratumumab Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Daratumumab Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Daratumumab Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Daratumumab by Countries

    • 9.1 Middle East and Africa Daratumumab Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Daratumumab Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Daratumumab Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Daratumumab Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Daratumumab Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Daratumumab Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Daratumumab Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Daratumumab Sales and Growth Rate (2014-2019)

    10 Global Daratumumab Market Segment by Type

    • 10.1 Global Daratumumab Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Daratumumab Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Daratumumab Revenue and Market Share by Type (2014-2019)
    • 10.2 100mg Injection Sales Growth and Price
      • 10.2.1 Global 100mg Injection Sales Growth (2014-2019)
      • 10.2.2 Global 100mg Injection Price (2014-2019)
    • 10.3 400mg Injection Sales Growth and Price
      • 10.3.1 Global 400mg Injection Sales Growth (2014-2019)
      • 10.3.2 Global 400mg Injection Price (2014-2019)

    11 Global Daratumumab Market Segment by Application

    • 11.1 Global Daratumumab Sales Market Share by Application (2014-2019)
    • 11.2 Multiple Myeloma Sales Growth (2014-2019)
    • 11.3 Diffuse Large B Cell Lymphoma Sales Growth (2014-2019)
    • 11.4 Follicular Lymphoma Sales Growth (2014-2019)
    • 11.5 Mantle Cell Lymphoma Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Daratumumab Market Forecast (2019-2024)

    • 12.1 Global Daratumumab Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Daratumumab Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Daratumumab Market Forecast (2019-2024)
      • 12.2.2 Europe Daratumumab Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Daratumumab Market Forecast (2019-2024)
      • 12.2.4 South America Daratumumab Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Daratumumab Market Forecast (2019-2024)
    • 12.3 Daratumumab Market Forecast by Type (2019-2024)
      • 12.3.1 Global Daratumumab Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Daratumumab Market Share Forecast by Type (2019-2024)
    • 12.4 Daratumumab Market Forecast by Application (2019-2024)
      • 12.4.1 Global Daratumumab Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Daratumumab Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Daratumumab . Industry analysis & Market Report on Daratumumab is a syndicated market report, published as Global Daratumumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Daratumumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,846.64
      		4,269.96
      		5,693.28
      		3,379.08
      		5,068.62
      		6,758.16
      		541,070.40
      		811,605.60
      		1,082,140.80
      		301,507.20
      		452,260.80
      		603,014.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo